Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
pathologic documentation of non-small cell lung cancer (NSCLC)
tumor must be accessible by bronchoscopy for tumor tissue sample collection
patients must have lung cancer with clinical stage IB, II, IIIA
Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
patients must not have received prior systemic chemotherapy or radiation therapy for NSCLC (prior resection of lung is allowed provided at least 5 years have elapsed between prior surgery and enrolment)
You may not be if
bronchoalveolar carcinoma or stage IIIA tumor involving the superior sulcus (Pancoast tumors)
pregnant or breast feeding patients
patients who have received treatment within the last 30 days with a drug that has not received regulatory approval for any indication at the time of study entry
patients with history or presence of other malignancy except in situ carcinoma of the skin or prior malignancy treated more than 5 years before without recurrence (excluding melanoma, breast cancer and hypernephroma)
unwillingness to take folic acid or vitamin B12 supplementation
